Thumann-Schweitzer C, Gosselin G, Périgaud C, Benzaria S, Girardet J L, Lefebvre I, Imbach J L, Kirn A, Aubertin A M
Institut de Virologie de la Faculté de Médecine de Strasbourg, Unité INSERM 74, France.
Res Virol. 1996 Mar-Jun;147(2-3):155-63. doi: 10.1016/0923-2516(96)80230-5.
Mononucleoside phosphotriester derivatives of dideoxynucleosides, following intracellular enzymatic activation, are likely to liberate their parent 5'-nucleoside monophosphate. Prodrugs of 3'-azido-2',3'-dideoxythymidine (AZT), 2',3'-didehydro-2',3'- dideoxythymidine (d4T), 2',3'-dideoxyinosine (ddl) and 2',3'-dideoxyadenosine (ddA) were evaluated for their anti-HIV1 activities in monocyte-derived macrophages, cells which are known to have low levels of nucleoside kinases. Prodrugs were found to be much more active, or just as active, as the corresponding dideoxynucleoside. Furthermore, their selectivity index was enhanced by a factor of 2 to 200.
双脱氧核苷的单核苷磷酸三酯衍生物在细胞内酶促激活后,可能会释放出其母体5'-核苷单磷酸。对3'-叠氮-2',3'-双脱氧胸苷(AZT)、2',3'-二脱氢-2',3'-双脱氧胸苷(d4T)、2',3'-双脱氧肌苷(ddI)和2',3'-双脱氧腺苷(ddA)的前药在单核细胞衍生的巨噬细胞中进行了抗HIV-1活性评估,已知这些细胞中核苷激酶水平较低。发现前药比相应的双脱氧核苷活性高得多,或活性相当。此外,它们的选择性指数提高了2至200倍。